Gene Therapies

Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2025202420232022 →
R&D project spotlight: Deciphering rAAV production dynamics in HEK293 clones through multi-omics profilingR&D project spotlight: Deciphering rAAV production dynamics in HEK293 clones through multi-omics profilingThe case for collaboration: Why going it alone is no longer an option in advanced therapy developmentThe case for collaboration: Why going it alone is no longer an option in advanced therapy developmentChallenge Theme R&D spotlight: CGT Catapult HEK cell line developed to optimise rAAV vector productionChallenge Theme R&D spotlight: CGT Catapult HEK cell line developed to optimise rAAV vector productionCGT Catapult, Pharmaron Biologics (UK) Ltd and Complement Therapeutics receive £1.4m grant to develop a perfusion process to improve production of gene therapiesCGT Catapult, Pharmaron Biologics (UK) Ltd and Complement Therapeutics receive £1.4m grant to develop a perfusion process to improve production of gene therapiesCGT Catapult establishes consortium to improve AAV formulationCGT Catapult establishes consortium to improve AAV formulationChallenge Theme R&D spotlight: Development of an end-to-end scalable AAV platformChallenge Theme R&D spotlight: Development of an end-to-end scalable AAV platformUK and Swiss consortium to apply innovative technologies to lower cost of manufacturing cell and gene therapiesUK and Swiss consortium to apply innovative technologies to lower cost of manufacturing cell and gene therapiesTouchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapiesTouchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapiesCell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesPress Release: AAV reference material to be produced at the Cell and Gene Therapy Catapult Braintree in collaboration with the National Institute for Biological Standards and ControlPress Release: AAV reference material to be produced at the Cell and Gene Therapy Catapult Braintree in collaboration with the National Institute for Biological Standards and ControlPress release: CombiGene and CGT Catapult collaboration completes development of quality control analytical assays for clinical production of CombiGene’s AAV-based gene therapy for the treatment of epilepsyPress release: CombiGene and CGT Catapult collaboration completes development of quality control analytical assays for clinical production of CombiGene’s AAV-based gene therapy for the treatment of epilepsy